This information is for research and educational purposes only. No medical recommendations. Products are not approved for human use. For health questions, consult a doctor.

Lexicon

GDF-8 (Myostatin)

Myostatin itself - the body's own brake on muscle growth, here as a lab reagent, NOT a mass builder.

5 min read 9 sources

GDF-8 vial labelled myostatin with the black TPD label on a white podium, next to a large blue 3D model of a folded protein chain in a bright lab
Lab reagent, preclinical · not approved

Summary

At a glance

Sources checked on 26 Oct 2026

Muscle weight without GDF-8
~2.5 -fold

single muscles of mice without the gene weighed 2 to 3 times as much1

Muscle mass with extra follistatin
~4 -fold

mice without myostatin plus a follistatin gene, compared with normal mice5

With GDF-8 as the agent
0 trials

the registry trials test blockers of myostatin, not GDF-8 itself (as of 26 Oct 2026)9

  • GDF-8 is myostatin itself, the body's own brake on muscle growth. It is not a myostatin blocker and not a muscle builder.1
  • Mice without the gene have markedly more muscle: single muscles weighed 2 to 3 times as much. Cattle breeds with double muscling carry mutations in the same gene.14
  • GDF-8 binds to the activin receptor IIB. In cell culture it holds muscle precursor cells in the G1 phase, so they stop dividing.32
  • Blocking the signal, for example with follistatin, gives mice more muscle. Injected GDF-8 would work in the opposite direction.35
  • As a vial GDF-8 is a lab reagent. It has not been studied as an agent in humans, everything here is research, not a recommendation.9
Profile

Updated June 2026

What it is
Myostatin itself

TGF-beta family

Function
Brakes muscle growth

does not build it

Use
Lab reagent / assay standard
Evidence
Purely preclinical

cell + mouse

Sizes
1 mg

1 size in the shop

Contents 15 sections
  1. At a glance
  2. What is GDF-8?
  3. How it works
  4. What you need
  5. Reconstitution
  6. Injection
  7. Dosing
  8. What the research shows
  9. Research status
  10. Side effects
  11. Storage
  12. Related compounds
  13. FAQ
  14. Glossary
  15. Sources

What is GDF-8?

The most important point first, because it is widely misunderstood: GDF-8 is myostatin itself. It is not a myostatin blocker and not a muscle-building compound. It is the exact protein your body uses to actively brake muscle growth.

Growth/Differentiation Factor 8 (GDF-8), gene name MSTN, belongs to the TGF-beta superfamily and was described in 1997 as the negative regulator of skeletal muscle mass. Your body makes it precisely so muscles don't grow without limit. Mice lacking the gene carry 2 to 3 times the normal muscle mass.

If you want muscle growth, this compound is completely wrong. Injected GDF-8 would work against muscle building, not promote it. What actually adds muscle in this space are myostatin inhibitors (substances that block GDF-8) - the exact opposite of what sits in this vial.

Why GDF-8 exists as a vial at all: as a research reagent and assay standard. Labs need pure myostatin protein to screen myostatin inhibitors, calibrate ELISA assays or study signalling in cell culture. This information is provided strictly for research and educational purposes. No medical recommendations.

Comparison

The brake and its opponents

GDF-8 is the messenger itself. According to the lexicon the other entries act on its effect, they release the brake.

How it works

GDF-8 is made as a larger precursor protein and then cleaved. The active piece binds the activin type II receptor (mainly ActRIIB) on the muscle cell and triggers a signalling cascade that throttles growth.

In cell culture the detail is clear: myostatin holds muscle precursor cells (myoblasts) in the G1 phase of the cell cycle, so they never enter division. It does this by raising the brake p21 and lowering Cdk2 - classic stop signals for cell division. Result: fewer new muscle cells, less growth.

That is exactly why the picture flips when you remove or block myostatin: in mouse models, both knocking out the gene and blocking the signal (with propeptide, follistatin or a silenced receptor) produced dramatically more muscle. That is the core: myostatin is the brake. Injecting GDF-8 means pressing that brake.

Important framing: all of this is described in cells and mice. How injected GDF-8 protein behaves in humans has not been studied.

Where it acts

Where GDF-8 brakes

Tap a point or a card. Colour = receptor, grey = observed. All from cell and animal studies.

  1. Skeletal muscle

    Brakes growth, muscle precursor cells stay in the G1 phase2

    ActRIIB
  2. Blood

    Made in muscle and circulates in the blood7

    Observed in trials

Known targets3

Compound UniProt O14793 (GDF-8): two described targets, type of action on each card.

Activin receptor type IIB
Gene
ACVR2B
UniProt
Q13705
ChEMBL
CHEMBL5466
Action
Main receptor, GDF-8 binds directly
Activin receptor type IIA
Gene
ACVR2A
UniProt
P27037
ChEMBL
CHEMBL5616
Action
Binds GDF-8 more weakly
Elongated glass cells in a row with blue 3D protein models sitting on them like at docking sites
Symbolic image.

What you need

Note up front: this list describes how a lyophilised protein is prepared in a lab context, not an application recommendation. For a clean reconstitution you'd have:

Supplies

5 things, numbered as in the picture

Tick off what you already have. Vial and BAC water are our real shop photos at the same size.

GDF-8 vial labelled myostatin and bacteriostatic water at the same size with the black TPD label, next to two U-100 insulin syringes, two alcohol swabs and a sharps container with a blue lid
  1. GDF-8 vial

    The GDF-8 vial with the freeze-dried powder

    In the shop
  2. Bacteriostatic water

    Bacteriostatic water for dissolving

    In the shop
  3. U-100 insulin syringes

    U-100 insulin syringes for drawing small volumes precisely

  4. Alcohol swabs

    Alcohol swabs for the vial cap

  5. Sharps container

    A sealable sharps container for used needles

As an Amazon associate we earn from qualifying purchases. Links open Amazon - no extra cost for you.

Because a 1mg vial is a very small, concentrated amount of protein, precision matters more here than with larger vials.

Reconstitution

The powder is dissolved with bacteriostatic water. How much water you use sets the concentration of the solution. With a 1mg vial, 1 ml of water gives a concentration of 1 mg/ml - which keeps the math simple.

Use the peptide calculator for exactly this: pick vial size and water volume and you immediately see the resulting concentration. Add the water in, it does not matter if it hits the powder directly, then swirl or shake until everything has dissolved, both are fine.

Step by step

Dissolving the powder

Four steps, the same for every vial size.

  1. 1Wipe the cap

    Clean the rubber stopper with an alcohol swab.

  2. 2Add BAC water

    Just add it, it does not matter if it hits the powder directly.

  3. 3Swirl or shake

    Until everything has dissolved, both are fine.

  4. 4Draw up

    With the U-100 insulin syringe.

Less water higher concentration fewer units on the syringe Example: 1 mg + 1 ml = 1 mg/ml

Injection

We deliberately give no human-use instructions here. GDF-8 is a research protein that brakes muscle growth - there is no sensible reason to inject it and no evidence base supporting that.

In a lab context the dissolved solution is pipetted or dosed into cell-culture/assay setups, not applied to a body. If you landed on this page looking for muscle growth: this is the wrong substance. Look for compounds that block myostatin, not myostatin itself.

Dosing

Dosing

Dosing, titration and syringe

Loading the dosing information …

  • Getting started and stepping up, drawn as a staircase
  • Units on the U-100 syringe for every step
  • How long one vial lasts

What the research shows

The evidence is scientifically well worked out - but it consistently shows the same thing: GDF-8 limits muscle, it does not build it.

  • 1997, Nature: Mice without a working GDF-8 gene carry 2 to 3 times the muscle mass - through more and larger muscle cells. This defined GDF-8 as a negative regulator (mouse model, preclinical).
  • 2000, JBC: Myostatin holds myoblasts in G1 via p21 upregulation and reduced Cdk2 - it directly brakes cell division (cell culture, preclinical).
  • 2001, PNAS: Blocking the myostatin signal (with propeptide, follistatin or a silenced ActRIIB receptor) produced massively more muscle in mice - comparable to the knockout (mouse model, preclinical).

The honest read: the muscle-building effect comes from removing myostatin. GDF-8 itself is the substance you'd want to switch off to get that. There are no human data on injected GDF-8 protein as an application.

Study results

What the trials measured

Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.

Muscle mass when the brake is missing5

Compared with normal mice, as a multiple

Muscle mass across the body5 approximate values according to the abstract
Normal mice 1-fold
Without the myostatin gene 2-fold
Without myostatin, plus a follistatin gene 4-fold

According to the abstract, mice without myostatin have about twice the muscle mass, with an extra follistatin gene about four times as much as normal mice. So follistatin blocks further growth brakes besides myostatin. Genetically modified animals, not a compound given from outside.

Shelf in an incubator with petri dishes, holding a glass bundle of reddish muscle fibres next to a glass padlock
Symbolic image.

Research status

Where the research stands

The registry has 35 hits for myostatin. No trial gives GDF-8 as an agent, the drug trials test antibodies that block myostatin. As of 26 Oct 2026. 9

  1. Preclinical Discovered in 1997, cell culture and mouse models
  2. Phase 1 no registered trial
  3. Phase 2 no registered trial
  4. Phase 3 no registered trial
  5. Approval not yet
Not approved and no trial with GDF-8 as an agent. It is used as a lab reagent.9

So far there is no registered trial in humans. 9

Side effects

Because GDF-8 has not been studied as a human application, there is no reliable side-effect profile from human trials - that is the honest answer.

Mechanistically the direction is clear: more myostatin signal means less muscle growth. A compound that strengthens the body's own growth brake is the opposite of what anyone wants in a performance context. Treating it as a research reagent and not injecting it is the only sensible stance.

Storage

The undissolved powder is robust, normal room temperature (around 20 to 25 degrees) is fine, ideally kept in the dark. Once mixed, it keeps for at least 2 to 3 months in the fridge (2 to 8 °C). Proteins like GDF-8 are fragile - avoid repeated freeze-thaw cycles and hard shaking, which can destroy the structure. The bacteriostatic water carries a preservative that keeps the dissolved form stable somewhat longer.

Shelf life

How long it keeps

Undissolved (powder) Room temperature, around 20 to 25 degrees, dark

Robust, no fridge needed. Keeps for several months without trouble.

Dissolved (mixed) Fridge, 2 to 8 degrees

Keeps for at least 2 to 3 months. Avoid repeated freeze-thaw cycles and hard shaking.

  • Keep it dark
  • Dissolved: 2 to 8 degrees
  • Note the mixing date on the vial
Nine vials with white powder and blue caps in the door shelf of a bright fridge
Powder dark at room temperature, once dissolved into the fridge (2 to 8 degrees), stable there for at least 2 to 3 months. Do not freeze and thaw repeatedly. Symbolic image.

Related

Related compounds

A different path: all in the TPD lexicon.

FAQ

Common questions about GDF-8 (Myostatin)

Short answers, each backed by the sources below.

Does GDF-8 build muscle?

No, the opposite. GDF-8 is myostatin, the body's own brake on muscle growth. Mice without the gene are markedly more muscular, single muscles weighed 2 to 3 times as much. More muscle comes from missing or blocked myostatin, not from extra GDF-8.1

How does GDF-8 brake growth?

The active form binds to the activin receptor IIB, more weakly to IIA. In cell culture myostatin held muscle precursor cells in the G1 phase: the brake p21 rose, Cdk2 fell and the cells stopped dividing. Follistatin and the propeptide can prevent binding to the receptor.32

Are there people and animals without myostatin?

Yes. The cattle breeds Belgian Blue and Piedmontese carry mutations in the myostatin gene and are double-muscled. In 2004 a Berlin group described a child with a mutation in the myostatin gene and strikingly strong muscles.46

What do labs use GDF-8 for?

As a pure protein for experiments. In 2001 a group used purified myostatin to measure its binding to the activin receptors and to test which substances prevent this binding. That is how blockers of myostatin can be found and compared.3

Are there human trials?

Not with GDF-8 as an agent. On ClinicalTrials.gov the drug trials test antibodies that block myostatin, for example a completed phase 3 trial in spinal muscular atrophy with 188 participants. That is the opposite of GDF-8.98

Which risks are known?

There are no human data because GDF-8 has never been tested as an agent. According to the cell and animal data the direction is clear: more myostatin signal means less division of muscle precursor cells and less muscle growth.21

Glossary

Terms explained briefly

Dotted words in the text open these explanations directly.

Activin receptor IIB
Receptor on muscle cells that myostatin binds to. Abbreviated ActRIIB.
Follistatin
Body's own protein that captures myostatin and activin and so releases the brake.
G1 phase
Stage of the cell cycle before the genetic material is copied. A cell that stops here does not divide.
Knockout
An animal in which a gene has been switched off on purpose to find out its job.
Lyophilisate
Freeze-dried powder. Without water a protein stays stable much longer.
Myoblasts
Muscle precursor cells. They divide and then fuse into muscle fibres.
Myostatin
Another name for GDF-8: a messenger that limits skeletal muscle growth.
Preclinical
Research in cell cultures and animal models, before first use in humans.
TGF-beta family
Large family of growth and differentiation factors that also includes myostatin and activin.

Evidence

Sources

Show all 9 sourcesHide sources 7 Studies2 Trial registry checked 26 Oct 2026

Studies

  1. Discovery of GDF-8: mice without the gene have much more muscle

    McPherron, Lawler und Lee, Nature, 1997

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  2. Myostatin stops muscle precursor cells from dividing

    Thomas et al., Journal of Biological Chemistry, 2000

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  3. Binding to activin receptors and inhibition by follistatin

    Lee und McPherron, PNAS, 2001

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  4. Double muscling in cattle from mutations in the myostatin gene

    McPherron und Lee, PNAS, 1997

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  5. Four-fold muscle mass in mice without myostatin plus follistatin

    Lee, PLoS ONE, 2007

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  6. Child with a myostatin mutation and strong muscles

    Schuelke et al., New England Journal of Medicine, 2004

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  7. Follistatin gene therapy in monkeys (describes myostatin as a blood-borne messenger)

    Kota et al., Science Translational Medicine, 2009

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed

Trial registry

  1. Phase 3 trial with a myostatin antibody (SAPPHIRE)

    ClinicalTrials.gov, NCT05156320

    Checked 26 Oct 2026 via ClinicalTrials.gov API v2
  2. Search on ClinicalTrials.gov (no trial with GDF-8 as an agent)

    ClinicalTrials.gov, U.S. National Library of Medicine

    Checked 26 Oct 2026 via ClinicalTrials.gov API v2

In the shop

GDF-8 (Myostatin) in the catalog

Sizes, prices and shipping times are on the product page.

To the product